<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        91-368-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BRIMO
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BRIMONIDINE TARTRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        38.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01EA05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Brimo&trade; is used to reduce pressure within the eye.<br />It can be used either alone, when beta-blocker eye<br />drops are contraindicated, or with another eye drop,<br />when a single medicine is not enough to lower the<br />increased pressure in the eye, in the treatment of<br />open angle glaucoma or ocular hypertension.<br />The active ingredient in Brimo&trade; is brimonidine<br />tartrate, which works by reducing pressure within<br />the eyeball.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Brimo&trade;<br />&bull; If you are allergic (hypersensitive) to brimonidine<br />tartrate or any of the other ingredients of Brimo&trade;.<br />&bull; If you are taking monoamine oxidase (MAO)<br />inhibitors or certain antidepressants. You must<br />inform your doctor if you are taking any<br />antidepressant drug.<br />&bull; If you are breast-feeding.<br />&bull; In infants/babies (from birth until 2 years).</p><p>Take special care with Brimo&trade;<br />Before you take this medicine, tell your doctor:<br />&bull; If you suffer or have suffered from depression,<br />reduced mental capacity, reduced blood supply to<br />the brain, heart problems, a disturbed blood supply<br />of the limbs or a blood pressure disorder.<br />&bull; If you have or have had in the past kidney or liver<br />problems.<br />&bull; If being given to a child between the age of 2 and<br />12 years because Brimo&trade; is not recommended for<br />use in this age group.</p><p>Using other medicines<br />Please tell your doctor or pharmacist if you are<br />taking or have recently taken any other medicines,<br />including medicines obtained without a prescription.</p><p>Tell your doctor if you are taking any of the<br />following medicines:<br />&bull; pain killers, sedatives, opiates, barbiturates or are<br />regularly consuming alcohol. &bull; anaesthetics.<br />&bull; to treat a heart condition or to lower blood<br />pressure. &bull; that can affect the metabolism like<br />chlorpromazine, methylphenidate and reserpine.<br />&bull; which work on the same receptor as Brimo&trade;, for<br />example isoprenaline and prazosin.<br />&bull; monoamine oxidase (MAO) inhibitors and other<br />antidepressants. &bull; medicines for any condition, even<br />if unrelated to your eye condition.<br />&bull; or if the dose of any of your current medicines is<br />changed.<br />These could affect your treatment with Brimo&trade;.</p><p>Pregnancy and breast-feeding<br />Ask your doctor or pharmacist for advice before<br />taking any medicine. Tell your doctor if you are<br />pregnant or planning to become pregnant.<br />Brimo&trade; should not be used while breast-feeding.</p><p>Driving and using machines<br />&bull; Brimo&trade; may cause blurred or abnormal vision.<br />This effect may seem worse at night or in reduced<br />lighting.<br />&bull; Brimo&trade; may also cause drowsiness or tiredness in<br />some patients.<br />&bull; If you experience any of these symptoms, do not<br />drive or use machinery until the symptoms are<br />cleared.</p><p>Important information about some of the<br />ingredients of Brimo&trade;<br />A preservative in Brimo&trade; (benzalkonium chloride)<br />may cause eye irritation and is also known to<br />discolour soft contact lenses. Therefore, avoid<br />contact with soft lenses. If you wear soft contact<br />lenses take them out before using these eye drops<br />and then wait 15 minutes after using Brimo&trade; before<br />inserting your lenses.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Brimo&trade; exactly as your doctor has told<br />you. You should check with your doctor or<br />pharmacist if you are not sure.</p><p>Adults<br />The usual dose is one drop twice daily in the<br />affected eye(s), approximately 12 hours apart.</p><p>Children under 12 years<br />Brimo&trade; must not be used for infants below 2 years<br />of age.<br />Brimo&trade; is not recommended for use in children<br />(from 2 years until 12 years).</p><p>Instructions for using eye drops<br />Brimo&trade; comes as eye drops. Always wash your<br />hands before applying eye drops.</p><p>If you use Brimo&trade; with another eye drop, wait<br />5-15 minutes before applying the second eye drop.</p><p>Apply your eye drops in the following way:<br />- Unscrew the cap from the bottle, check the dropper<br />is clean.<br />- Pull your lower eyelid gently down, and then<br />carefully instill one drop inside the lower eyelid, in<br />the corner closest to the nose.<br />- Release the lower eyelid, and blink a few times to<br />make sure the eye is covered by the liquid.<br />- Repeat the procedure for your other eye, if it also<br />needs treatment.<br />- When you have finished, replace the protective cap<br />tightly to prevent spilling or spoilage.</p><p>If you use more Brimo&trade; than you should<br />Adults<br />In adults who were instilling more drops than<br />prescribed, the side effects reported were those<br />already known to occur with Brimo&trade;.<br />Adults who accidentally swallowed Brimo&trade;<br />experienced decrease in blood pressure, which in<br />some patients was followed by the increase in blood<br />pressure.</p><p>Children<br />Serious side effects were reported in children who<br />accidentally swallowed Brimo&trade;. Signs included<br />sleepiness, floppiness, low body temperature,<br />paleness and breathing difficulties. Should this<br />happen, contact your doctor immediately.</p><p>Adults and Children<br />If Brimo&trade; has been accidentally swallowed or if<br />you have used more Brimo&trade; than you should,<br />please contact your doctor immediately.</p><p>If you forget to use Brimo&trade;<br />If you forget to take a dose, apply it as soon as you<br />remember. If, however, it is almost time for your<br />next dose, you should omit the missed dose<br />altogether and then follow your normal routine.</p><p>If you stop using Brimo&trade;<br />To be effective Brimo&trade; must be used every day.<br />Do not stop using Brimo&trade; until your doctor tells<br />you to.<br />If you have any further questions on the use of this<br />product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Brimo&trade; can cause side effects,<br />although not everybody gets them. The chance of<br />having a side effect is described by the following<br />categories:<br />Very common: Occurs in more than 1 out of 10<br />patients.<br />Common: Occurs in fewer than 1 out of 10 patients.<br />Uncommon: Occurs in fewer than 1 out of 100<br />patients.<br />Rare: Occurs in fewer than 1 out of 1,000 patients.<br />Very rare: Occurs in fewer than 1 out of 10,000<br />patients.<br />The following eye side effects may be seen with<br />Brimo&trade;.<br />Affecting the eye<br />Very common:<br />&bull; Irritation of the eye (eye redness, burning,<br />stinging, a feeling of something in the eye, itching,<br />follicles or white spots on the see-through layer<br />which covers the surface of the eye).<br />&bull; Blurred vision.<br />&bull; An allergic reaction in the eye.<br />Common:<br />&bull; Local irritation (inflammation and swelling of the<br />eyelid, swelling of the see-through layer which<br />covers the surface of the eye, sticky eyes, pain and<br />tearing).<br />&bull; Sensitivity to light.<br />&bull; Erosion on the surface of the eye and staining.<br />&bull; Eye dryness.<br />&bull; Whitening of the see-through layer which covers<br />the surface of the eye.<br />&bull; Abnormal vision.<br />&bull; Inflammation of the see-through layer which<br />covers the surface of the eye.<br />Very rare:<br />&bull; Inflammation within the eye.<br />&bull; Reduction in pupil size.<br />Side effects where the occurrence is unknown:<br />&bull; Itching of eyelids.<br />Affecting the body<br />Very common:<br />&bull; Headache. &bull; Dry mouth. &bull; Tiredness/drowsiness.<br />Common:<br />&bull; Dizziness. &bull; Cold-like symptoms.<br />&bull; Symptoms involving the stomach and digestion.<br />&bull; Abnormal taste. &bull; General weakness.<br />Uncommon:<br />&bull; Depression.<br />&bull; Palpitations or changes in heart rate.<br />&bull; Dry nose. &bull; General allergic reactions.<br />Rare:<br />&bull; Shortness of breath.<br />Very rare:<br />&bull; Sleeplessness. &bull; Fainting. &bull; High blood pressure.<br />&bull; Low blood pressure.</p><p>Side effects where the occurrence is unknown:<br />&bull; Skin reactions including redness, face swelling,<br />itching, rash and widening of blood vessels<br />If any of the side effects gets serious, or if you<br />notice any side effects not listed in this leaflet,<br />please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not store above 30 &ordm;C.<br />&bull; Brimo&trade; eye drops are sterile when first opened, it<br />is important to keep the drops as clean as possible<br />during use.<br />&bull; Do not use Brimo&trade; after the expiry date which is<br />stated on the bottle label and the bottom of the<br />carton after EXP.<br />&bull; Once opened the drops should not be used for<br />longer than one month.<br />&bull; Medicines should not be disposed of via<br />wastewater or household waste. Ask your<br />pharmacist how to dispose of medicines no longer<br />required. These measures will help to protect the<br />environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is brimonidine tartrate.<br />One ml solution contains 2.0 mg brimonidine<br />tartrate, equivalent to 1.3 mg of brimonidine.<br />&bull; The other ingredients are benzalkonium chloride,<br />citric acid, hydrochloric acid or sodium hydroxide<br />(to adjust pH), polyvinyl alcohol, sodium chloride,<br />sodium citrate and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                • Brimo™ eye drops is a clear, pale yellow colored solution free from visible particles.
• Brimo™ eye drops solution , 5 ml filled in LDPE bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Factory Co.,<br />Jeddah, Makkah Region, Saudi Arabia.<br />Tel: +966-12-6081111 Fax: +966-12-6081222<br />Website: www.jamjoompharma.com<br />Please report adverse drug events to:<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance Centre (NPC):<br />o Fax: +966-11-205-7662<br />o SFDA Call Center: 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: https://ade.sfda.gov.sa<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.<br />This leaflet was last reviewed at 07/2024;<br />Version number 03.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 07-2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>تُستخدم بريمو لخفض ضغط الدم المرتفع داخل العينين.&nbsp;<br />يمكن أن تُستخدم بريمو بمفردها عندما تكون قطرات العينين&nbsp;<br />من عائلة حاصرات بيتا ممنوعة من الإستخدام، أو مع نوع آخر<br />عندما يكون إستخدام نوع واحد من القطرات غير كافٍ لخفض<br />ضغط الدم المرتفع داخل العين و ذلك في علاج حالات الزَرَق<br />(الجلوكوما أو المياه الزرقاء) مفتوحة الزاوية أو ارتفاع ضغط<br />العين.<br />- المادة الفعالة في بريمو هي تارتارات البريمونيدين و التي&nbsp;<br />تعمل عن طريق خفض الضغط داخل مقلة العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم بريمو<br />&bull; إذا كنت تعاني من فرط الحساسية للبريمونيدين أو أي من<br />الأخرى&nbsp;مكونات بريمو<br />&bull; إذا كنت تتناول مثبطات انزيم أحادي أوكسيد الأمين (MAO)<br />أو مضادات إكتئاب معينة و يجب عليك إخبار طبيبك إذا كنت<br />تتناول أي مضادات للإكتئاب.<br />&bull; إذا كنتِ تقومين بالرضاعة الطبيعية.<br />&bull; في الأطفال /الرضع (منذ الولادة و حتى سن سنتين).<br />&trade; إتخذ إحتياطات خاصة عند إستخدام بريمو<br />قبل إستخدامك لهذا الدواء قم بإخبار طبيبك<br />&bull; إذا كنت تعاني أو عانيت من الإكتئاب سابقاً أو نقص القدرة<br />الذهنية أو تدفق الدم للمخ أو مشاكل في القلب أو اضطراب في<br />تدفق الدم للأطراف أو في ضغط الدم.<br />&bull; إذا كنت تعاني أو عانيت سابقاً من مشاكل في الكلى.<br />&bull; إذا تم إستخدام بريمو للأطفال في سن ما بين ۲ إلى ۱۲ سنة &trade;<br />&nbsp;لأنه لا ينصح بإستخدام بريمو لهذه المرحلة العمرية.<br />إستخدام أدوية أخرى<br />من فضلك قم بإخبار الطبيب أو الصيدلي الخاص بك إذا كنت<br />تتناول أو تناولت مؤخرا أي أدوية أخرى بما في ذلك الأدوية<br />التي يتم صرفها بدون وصفة طبية.<br />قم بإخبار طبيبك إذا كنت تأخذ أي من الأدوية الآتية:<br />&bull; المسكنات، المهدئات، المنومات من مشتقات الأفيون، إستخدام<br />الكحوليات بإنتظام.<br />&bull; الأدوية المخدرة &quot;المُبنِجات&quot;.<br />&bull; أدوية القلب أو الضغط المرتفع.<br />&bull; الأدوية التي يمكن أن تؤثر على الأيض مثل الكلوربرومازين<br />و الميثيل فينيدات و الريسيربين.<br />&bull; الأدوية التي تعمل عن طريق نفس المستقبلات التي يعمل<br />مثل ايزوبرينالين و بروزاسين.&nbsp; عليها بريمو<br />&bull; مثبطات أحادي أوكسيد الأمين و مضادات الإكتئاب الأخرى.<br />&bull; أدوية لعلاج أي حالات أخرى حتى وإن لم تكن لها علاقة<br />بحالة عينيك.<br />&bull; إذا تغيرت جرعة أي من الأدوية التي تستخدمها حالياً لأن هذا<br />&nbsp;يمكن أن يؤثر على علاجك مع بريمو<br />الحمل و الإرضاع<br />إستشيري طبيبك أو الصيدلي قبل تناول أي أدوية و أخبريه إذا<br />كنتِ أو تخططين لتصبحي حاملاً.<br />لا تستخدمي بريمو مع الرضاعة الطبيعية.&nbsp;<br />قيادة المركبات و تشغيل الآلات<br />يمكن أن تتسبب بريمو في رؤية ضبابية أو غير طبيعية و<br />هذا التأثير يمكن ان يزداد ليلاً في الضوء الخافت.<br />يمكن أن تتسبب بريمو أيضاً في الشعور بالنعاس أو&nbsp;&nbsp;<br />الإجهاد عند بعض المرضى. إذا شعرت بأي من هذه الأعراض<br />لا تقم بالقيادة أو إستخدام الآلات حتى تزول.<br />معلومات هامة عن بعض مكونات بريمو&nbsp;</p><p>&nbsp; &bull; كلوريد البنزالكونيوم هو المادة الحافظة في بريمو&nbsp;و الذي<br />يمكن أن يتسبب في تهيج بالعين و من المعروف عنه أيضاً ان<br />بريمو&nbsp;يُفقد العدسات اللاصقة الرخوة لونها لذا تجنب ملامسة<br />مع العدسات اللاصقة.<br />&bull; إذا كنت تستخدم العدسات اللاصقة الرخوة قم بخلعها قبل&nbsp; إستخدام بريمو ثم انتظر ۱٥ دقيقة بعد إستخدام بريمو&nbsp;قبل<br />وضع عدساتك اللاصقة مرة أخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>إستخدم بريمو دائماً كما وصفها لك الطبيب و إذا لم تكن<br />متأكداً قم بسؤال طبيبك أو الصيدلي.<br />البالغين:<br />الجرعة المعتادة هي نقطة واحدة مرتين يومياً &quot;يفصل بينهما<br />۱۲ ساعة تقريباً) في العين المصابة.<br />الأطفال أقل من ۱۲ سنة:<br />&bull; يجب عدم إستخدام بريمو للأطفال في عمر أقل من سنتين.&nbsp;<br />&bull; لا يُنصح بإستخدام بريمو للأطفال من سن ۲ وحتى ۱۲&nbsp;&nbsp;سنة.<br />تعليمات الإستخدام:<br />تأتي بريمو في صورة قطرة للعين.<br />&bull; قم بغسل يديك دائماً قبل إستخدام قطرات العين.<br />&bull; إذا كنت تستخدم نوع آخر من القطرات مع بريمو&nbsp;انتظر&nbsp;<br />۱٥ دقيقة قبل أن تستخدم النوع الآخر من القطرات.</p><p>-٥ إرشادات إستخدام قطرات العين<br />&bull; قم بلف الغطاء من الزجاجة، وتحقق من أن القطارة نظيفة.<br />&bull; إسحب الجفن السفلي إلى أسفل برفق، ومن ثم ضع بعناية<br />قطرة واحدة داخل الجفن السفلي، في الزاوية الأقرب إلى الأنف.<br />&bull; حرر الجفن السفلي، أغلق وافتح العين عدة مرات للتأكد من<br />تغطية العين عن طريق السائل.<br />&bull; إذا كنت تستخدم بريمو في كلتا العينين كرر نفس الخطوات&nbsp;<br />للعين الأخرى.إذا كانت هي أيضاً تحتاج للعلاج.<br />&bull; قم بإعادة غطاء الزجاجة الى مكانه مباشرة بعد الإستخدام وقم<br />بإحكام الغلق.<br />إذا استخدمت كمية أكثر من اللازم:<br />في البالغين<br />في البالغين الذين قاموا بتقطير كمية أكثر من الموصوف فإن<br />الآثار الجانبية التي تم ملاحظتها هي نفسها المسجلة عند&nbsp; إستخدام بريمو.<br />يحدث انخفاض&nbsp;في ضغط الدم يعقبه ارتفاع أحياناً مع بعض المرضى البالغين الذين ابتلعوا بطريق الخطأ بريمو<br /><br />في الأطفال<br />تم ملاحظة آثار جانبية خطيرة عند بلع بريمو عن طريق&nbsp;<br />الخطأ من قبل الأطفال مثل النعاس و التثاقل و انخفاض درجة<br />حرارة الجسم و الشحوب و الصعوبة في التنفس و عند حدوث<br />ذلك اتصل بطبيبك مباشرة.<br />في البالغين و الأطفال<br />إذا أُبتلعت بريمو عن طريق الخطأ أو إذا قمت بإستخدام كمية<br />أكثر مما ينبغي، اتصل بطبيبك على الفور.<br />&nbsp;إذا نسيت إستخدام بريمو<br />إذا نسيت تناول إحدى الجرعات قم بأخذها بمجرد تذكرك إلّا إذا<br />كان قد حان موعد الجرعة التالية حينئذ يجب عليك تخطي<br />الجرعة المنسية ثم اتباع نظامك المعتاد.<br />&nbsp;إذا توقفت عن تناول بريمو<br />&bull; يجب أن تُستخدم بريمو بشكل يومي حتى تحصل على<br />المفعول المطلوب. لا تتوقف عن إستخدام بريمو&nbsp;حتى<br />يخبرك طبيبك بذلك.<br />&bull; إذا كان لديك أي استفسارات أخرى عن طريقة إستخدام هذا<br />المستحضر فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>يمكن أن تتسبب بريمو في حدوث أعراضاً جانبية مثلها في<br />ذلك مثل كل الأدوية الأخرى بالرغم من عدم تعرض جميع<br />الأشخاص لها.</p><p>المجموعات التالية تصف فرصة حدوث الأعراض الجانبية:<br />شائعة جداً: تحدث في أكثر من ۱ /۱۰ مرضى.&nbsp;<br />شائعة: تحدث في أقل من ۱/۱۰ مرضى.<br />&nbsp;إستثنائية: تحدث في أقل من۱/ ۱۰۰ مريض.<br />نادرة: تحدث في أقل من۱ /۱۰۰۰ مريض.&nbsp;<br />نادرة جداً: تحدث في أقل من۱ /۱۰۰۰۰ مريض.&nbsp;<br />يمكن ملاحظة الأعراض الجانبية التالية في العين عند<br />&nbsp;إستخدام بريمو<br />شائعة جداً:<br />&bull; تهيج في العين ( إحمرار، حرقان، وخز، شعور بوجود شيء<br />ما في العين، حكة، جُرَيبات أو بقع بيضاء على الطبقة الشفافة<br />التي تغطي سطح العين).<br />&bull; عدم وضوح في الرؤية.<br />&bull; رد فعل تحسسي في العين.<br />شائعة:<br />&bull; تهيج موضعي (التهاب و تورم للجفن، انتفاخ الطبقة الشفافة<br />التي تغطي سطح العين، لزوجة في العينين بسبب الإفرازات،<br />ألم و دموع).<br />&bull; الحساسية تجاه الضوء.<br />&bull; تقرحات وبقع ملونة في سطح العين.<br />&bull; جفاف في العين.<br />&bull; تحول الطبقة الشفافة التي تغطي سطح العين إلى اللون<br />الأبيض.<br />&bull; رؤية غير طبيعية.<br />&bull; التهاب في الطبقة الشفافة التي تغطي سطح العين.<br />نادرة جداً:<br />&bull; التهاب داخل العين.<br />&bull; صغر حجم حدقة العين.<br />أعراض جانبية غير محددة الحدوث:<br />&bull; حكة في جفن العين.<br />الأعراض المؤثرة على الجسم:<br />شائعة جداً:<br />&bull; صداع.<br />&bull; جفاف بالفم.<br />&bull; إرهاق و نعاس.<br />شائعة:<br />&bull; دوار.<br />&bull; أعراض مشابهة للزكام.<br />&bull; أعراض متعلقة بالمعدة و الهضم.<br />&bull; مذاق غير طبيعي.<br />&bull; ضعف عام.<br />إستثنائية:<br />&bull; إكتئاب.<br />&bull; خفقان أو تغيرات في نبضات القلب.<br />&bull; جفاف بالأنف.<br />&bull; تفاعلات تحسسية بوجه عام.<br />نادرة:<br />&bull; ضيق في التنفس.<br />نادرة جداً:<br />&bull; أرَقَ.<br />&bull; إغماء.<br />&bull; إرتفاع في ضغط الدم.<br />&bull; إنخفاض في ضغط الدم.<br />أعراض جانبية غير محددة الحدوث:<br />&bull; تفاعلات بالجلد تشمل إحمرار، انتفاخ بالوجه، حكة، طفح<br />جلدي واتساع في الأوعية الدموية.<br />إذا لاحظت تحول أي من الآثار الجانبية الى مرحلة أكثر<br />خطورة أو إذا لاحظت حدوث آثار جانبية أخرى غير مدرجة<br />في هذه النشرة يرجى إخبار طبيبك أو الصيدلي بها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول و مرأى الأطفال.<br />&bull; يحفظ في درجة حرارة لا تزيد عن ۳۰ درجة مئوية.<br />&bull; قطرات العين بريمو تكون معقمة عند فتحها لأول مرة، من&nbsp;<br />المهم أن تظل القطرات نظيفة بأكبر قدر ممكن خلال الإستخدام.<br />&nbsp;</p><p>&bull; لا تستخدم قطرة بريمو<br />بعد انتهاء تاريخ الصلاحية المدون&nbsp; على العلامة الملصقة على الزجاجة أو أسفل العبوة الكرتونية بعد كلمة&quot; EXP &quot;<br />&bull; بمجرد فتح العبوة فلا ينبغي استعمالها لمدة تزيد عن شهر<br />واحد.<br />&bull; لا يجب التخلص من الأدوية عن طريق مياه الصرف أو<br />النفايات المنزلية. إسأل الصيدلي عن طريقة التخلص من الأدوية<br />الغير مرغوب فيها فسوف تساعد هذه الإجراءات على حماية<br />البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي بريمونيدين تارتارات .<br />۱&cedil; يحتوي كل مل على ۲ ملغ بريمونيدين تارتارات مكافئ ل ۳<br />ملغ من البريمونيدين.<br />المكونات الأخرى هي:<br />كلوريد البنزالكونيوم، حمض الستريك، هيدروكسيد الصوديوم<br />أو حمض الهيدروكلوريك (لضبط درجة الحموضة)، بولي فينيل<br />الكحول، كلوريد الصوديوم، سيترات الصوديوم والماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">بريمو قطرة للعين، محلول نقي&nbsp;لونه أصفر باهت خالى من&nbsp;<br />الجسيمات المرئية.<br />&bull; بريمو قطرة للعين، محلول ٥ مل في قطارة من البولي&nbsp;<br />إيثيلين منخفض الكثافة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسویق و المصنع:<br />شركة مصنع جمجوم للأدویة ،<br />جدة، منطقة مكة، المملكة العربیة السعودیة.<br />الھاتف: +966-12-6081111<br />فاكس: +966-12-6081222<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبیھ:<br />&bull; المملكة العربیة السعودیة:<br />:(NPC) المركز الوطني للتیقظ الدوائي<br />&nbsp;فاكس: +966-11-205-7662<br />مركز اتصال الھیئة العامة للغذاء والدواء: ۱۹۹۹۹&nbsp;<br />npc.drug@sfda.gov.sa : برید إلكتروني o<br />https://ade.sfda.gov.sa : الموقع الالكتروني o<br />&bull; دول الخلیج الأخرى:<br />- الرجاء الاتصال بالمؤسسات و الھیئات الوطنیة<br />في كل دولة.</p><p>&nbsp;تم مراجعة ھذه النشرة في 07/2024<br />رقم النسخة ۰۳</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Brimo 0.2% w/v (2 mg/ml) eye drops, solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One ml solution contains 2.0 mg brimonidine tartrate, equivalent to 1.3 mg of brimonidine.
Excipient(s): Contains benzalkonium chloride 0.05 mg/ml. For a full list of excipients, see section
6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye drops, solution.
Clear, pale yellow colored solution free from visible particles, filled in 10 mL LDPE opaque bottle.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.<br />&minus; As monotherapy in patients in whom topical beta-blocker therapy is contraindicated.<br />&minus; As adjunctive therapy to other intraocular pressure lowering medications when the target IOP is not<br />achieved with a single agent (see Section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Recommended dosage in adults (including the elderly)</p><p>The recommended dose is one drop of Brimo in the affected eye(s) twice daily, approximately 12<br />hours apart. No dosage adjustment is required for the use in elderly patients.</p><p>As with any eye drops, to reduce possible systemic absorption, it is recommended that the lachrymal<br />sac be compressed at the medial canthus (punctal occlusion) for one minute. This should be<br />performed immediately following the instillation of each drop.</p><p>If more than one topical ophthalmic drug is to be used, the different drugs should be instilled 5-15<br />minutes apart.</p><p>Use in renal and hepatic impairment</p><p>Brimo has not been studied in patients with hepatic or renal impairment (see section 4.4).</p><p>Use in paediatric subjects</p><p>No clinical studies have been performed in adolescents (12 to 17 years).</p><p>Brimo is not recommended for use in children below 12 years and is contraindicated in neonates and<br />infants (less than 2 years of age) (see sections 4.3, 4.4 and 4.9). It is known that severe adverse<br />reactions can occur in neonates. The safety and efficacy of Brimo have not been established in<br />children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                   Hypersensitivity to the active substance or to any of the excipients.
   Neonates and infants (see section 4.8).
   Patients receiving monoamine oxidase (MAO) inhibitor therapy and patients on antidepressants
   which affect noradrenergic transmission (e.g. tricyclic antidepressants and mianserin).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Children of 2 years of age and above, especially those in the 2-7 age range and/or weighing &le; 20 Kg,<br />should be treated with caution and closely monitored due to the high incidence and severity of<br />somnolence (see section 4.8).</p><p>Caution should be exercised in treating patients with severe or unstable and uncontrolled<br />cardiovascular disease.</p><p>Some (12.7%) patients in clinical trials experienced an ocular allergic type reaction with Brimo (see<br />section 4.8 for details). If allergic reactions are observed, treatment with Brimo should be<br />discontinued.</p><p>Delayed ocular hypersensitivity reactions have been reported with Brimo 0.2%, with some reported<br />to be associated with an increase in IOP.</p><p>Brimo should be used with caution in patients with depression, cerebral or coronary insufficiency,<br />Raynaud&#39;s phenomenon, orthostatic hypotension or thromboangiitis obliterans.</p><p>Brimo has not been studied in patients with hepatic or renal impairment; caution should be used in<br />treating such patients.</p><p>The preservative in Brimo, benzalkonium chloride, may cause eye irritation. Avoid contact with soft<br />contact lenses. Remove contact lenses prior to application and wait at least 15 minutes before<br />reinsertion. Known to discolour soft contact lenses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Brimo is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy and<br />patients on antidepressants which affect noradrenagic transmission (e.g. tricyclic antidepressants and<br />miaserin), (see section 4.3).</p><p>Although specific drug interactions studies have not been conducted with Brimo, the possibility of an<br />additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, or<br />anaesthetics) should be considered.</p><p>No data on the level of circulating catecholamines after Brimo administration are available. Caution,<br />however, is advised in patients taking medications which can affect the metabolism and uptake of<br />circulating amines e.g. chlorpromazine, methylphenidate, reserpine.</p><p>After the application of Brimo, clinically insignificant decreases in blood pressure were noted in<br />some patients. Caution is advised when using drugs such as antihypertensives and/or cardiac<br />glycosides concomitantly with Brimo.</p><p>Caution is advised when initiating (or changing the dose of) a concomitant systemic agent<br />(irrespective of pharmaceutical form) which may interact with &alpha;-adrenergic agonists or interfere with<br />their activity i.e. agonists or antagonists of the adrenergic receptor e.g. (isoprenaline, prazosin).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety of use during human pregnancy has not been established. In animal studies, brimonidine<br />tartrate did not cause any teratogenic effects. In rabbits, brimonidine tartrate, at plasma levels higher<br />than are achieved during therapy in humans, has been shown to cause increased preimplantation loss<br />and postnatal growth reduction. Brimo should be used during pregnancy only if the potential benefit<br />to the mother outweighs the potential risk to the foetus.</p><p>It is not known if brimonidine is excreted in human milk. The compound is excreted in the milk of<br />the lactating rat. Brimo should not be used by women nursing infants.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Brimo may cause fatigue and/or drowsiness, which may impair the ability to drive or operate<br />machinery. Brimo may cause blurred and/or abnormal vision, which may impair the ability to drive<br />or to use machinery, especially at night or in reduced lighting. The patient should wait until these<br />symptoms have cleared before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported ADRs are oral dryness, ocular hyperaemia and burning/stinging, all<br />occurring in 22 to 25% of patients. They are usually transient and not commonly of a severity<br />requiring discontinuation of treatment.</p><p>Symptoms of ocular allergic reactions occurred in 12.7% of subjects (causing withdrawal in 11.5% of<br />subjects) in clinical trials with the onset between 3 and 9 months in the majority of patients.</p><p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.<br />The following terminologies have been used in order to classify the occurrence of undesirable effects:<br />Very Common (&ge;1/10); Common (&ge;1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare<br />(&ge;1/10,000 to &lt;1/1,000); Very rare (&lt;1/10,000), not known (cannot be estimated from the available<br />data).</p><p>Cardiac disorders</p><p>Uncommon: palpitations/arrhythmias (including bradycardia and tachycardia)</p><p>Nervous system disorders</p><p>Very common: headache, drowsiness</p><p>Common: dizziness, abnormal taste<br />Very rare: syncope<br />Eye disorders<br />Very common:<br />&minus; ocular irritation (hyperaemia, burning and stinging, pruritus, foreign body sensation, conjunctival<br />follicles)<br />&minus; blurred vision<br />&minus; allergic blepharitis, allergic blepharoconjunctivitis, allergic conjunctivitis, ocular allergic reaction,<br />and follicular conjunctivitis<br />Common:<br />&minus; local irritation (eyelid hyperaemia and oedema, blepharitis, conjunctival oedema and discharge,<br />ocular pain and tearing)</p><p>&minus; photophobia<br />&minus; corneal erosion and staining<br />&minus; ocular dryness<br />&minus; conjunctival blanching<br />&minus; abnormal vision<br />&minus; conjunctivitis<br />Very rare:<br />&minus; iritis<br />&minus; miosis<br />Respiratory, thoracic and mediastinal disorders<br />Common: upper respiratory symptoms<br />Uncommon: nasal dryness<br />Rare: dyspnoea<br />Gastrointestinal disorders<br />Very common: oral dryness<br />Common: gastrointestinal symptoms<br />Vascular disorders<br />Very rare: hypertension, hypotension<br />General disorders and administration site conditions<br />Very common: fatigue<br />Common: asthenia</p><p>Immune system disorders<br />Uncommon: systemic allergic reactions<br />Psychiatric disorders<br />Uncommon: depression<br />Very rare: insomnia<br />The following adverse reactions have been identified during post-marketing use of Brimo in clinical<br />practice. Because they are reported voluntarily from a population of unknown size, estimates of<br />frequency cannot be made:<br />Not known:<br />Eye disorders<br />- iridocyclitis (anterior uveitis)<br />- eyelid pruritus<br />Skin and subcutaneous tissue disorders</p><p>- Skin reaction including erythema, face oedema, pruritus, rash and vasodilatation</p><p>In cases where brimonidine has been used as part of the medical treatment of congenital glaucoma,<br />symptoms of brimonidine overdose such as loss of consciousness, lethargy, somnolence,<br />hypotension, hypotonia, bradycardia, hypothermia, cyanosis, pallor, respiratory depression and<br />apnoea have been reported in neonates and infants receiving brimonidine (see section 4.3).</p><p>In a 3-month, phase 3 study in children aged 2-7 years with glaucoma, inadequately controlled by<br />beta-blockers, a high prevalence of somnolence (55%) was reported with Brimo as adjunctive<br />treatment. In 8% of children, this was severe and led to discontinuation of treatment in 13%. The<br />incidence of somnolence decreased with increasing age, being least in the 7-year-old age group<br />(25%), but was more affected by weight, occurring more frequently in those children weighing &le;20<br />kg (63%) compared to those weighing &gt;20 kg (25%) (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ophthalmic overdose (Adults):</p><p>In those cases received, the events reported have generally been those already listed as adverse<br />reactions.</p><p>Systemic overdose resulting from accidental ingestion (Adults):</p><p>There is very limited information regarding accidental ingestion of brimonidine in adults. The only<br />adverse event reported to date was hypotension. It was reported that the hypotensive episode was<br />followed by rebound hypertension.</p><p>Treatment of oral overdose includes supportive and symptomatic therapy; patient&#39;s airways should be<br />maintained.</p><p>Oral overdoses of other alpha-2-agonists have been reported to cause symptoms such as hypotension,<br />asthenia, vomiting, lethargy, sedation, bradycardia, arrhythmias, miosis, apnoea, hypotonia,<br />hypothermia, respiratory depression and seizure.</p><p>Paediatric population</p><p>Reports of serious adverse effects following inadvertent ingestion of Brimo by paediatric subjects<br />have been published or reported to Allergan. The subjects experienced symptoms of CNS depression,<br />typically temporary coma or low level of consciousness, lethargy, somnolence, hypotonia,<br />bradycardia, hypothermia, pallor, respiratory depression and apnoea, and required admission to<br />intensive care with intubation if indicated. All subjects were reported to have made a full recovery,<br />usually within 6-24 hours.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Sympathomimetics in glaucoma therapy,<br />ATC code = S01EA 05.</p><p>Brimonidine is an alpha-2 adrenergic receptor agonist that is 1000-fold more selective for the alpha-2<br />adrenoceptor than the alpha-1 adrenoreceptor.</p><p>This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated<br />with human retinal xenografts.</p><p>Topical administration of brimonidine tartrate decreases intraocular pressure (IOP) in humans with<br />minimal effect on cardiovascular or pulmonary parameters.</p><p>Limited data are available for patients with bronchial asthma showing no adverse effects.</p><p>Brimo has a rapid onset of action, with peak ocular hypotensive effect seen at two hours post-dosing.<br />In two 1 year studies, Brimo lowered IOP by mean values of approximately 4-6 mmHg.</p><p>Fluorophotometric studies in animals and humans suggest that brimonidine tartrate has a dual<br />mechanism of action. It is thought that Brimo may lower IOP by reducing aqueous humour formation<br />and enhancing uveoscleral outflow.</p><p>Clinical trials show that Brimo is effective in combination with topical beta-blockers. Shorter term<br />studies also suggest that Brimo has a clinically relevant additive effect in combination with<br />travoprost (6 weeks) and latanoprost (3 months).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a) General characteristics<br />After ocular administration of a 0.2% solution twice daily for 10 days, plasma concentrations were<br />low (mean Cmax was 0.06 ng/ml). There was a slight accumulation in the blood after multiple (2<br />times daily for 10 days) instillations. The area under the plasma concentration-time curve over 12<br />hours at steady state (AUC0-12h) was 0.31 ng&middot;hr/ml, as compared to 0.23 ng&middot;hr/ml after the first<br />dose. The mean apparent half-life in the systemic circulation was approximately 3 hours in humans<br />after topical dosing.</p><p>The plasma protein binding of brimonidine after topical dosing in humans is approximately 29%.</p><p>Brimonidine binds reversibly to melanin in ocular tissues, in vitro and in vivo. Following 2 weeks of<br />ocular instillation, the concentrations of brimonidine in iris, ciliary body and choroid-retina were 3-<br />to 17-fold higher than those after a single dose. Accumulation does not occur in the absence of<br />melanin.</p><p>The significance of melanin binding in humans is unclear. However, no significant ocular adverse<br />reaction was found during biomicroscopic examination of eyes in patients treated with Brimo for up<br />to one year, nor was significant ocular toxicity found during a one year ocular safety study in<br />monkeys given approximately four times the recommended dose of brimonidine tartrate.</p><p>Following oral administration to man, brimonidine is well absorbed and rapidly eliminated. The<br />major part of the dose (around 75% of the dose) was excreted as metabolites in urine within five<br />days; no unchanged drug was detected in urine. In vitro studies, using animal and human liver,<br />indicate that the metabolism is mediated largely by aldehyde oxidase and cytochrome P450. Hence,<br />the systemic elimination seems to be primarily hepatic metabolism.</p><p>Kinetics profile:<br />No great deviation from dose proportionality for plasma Cmax and AUC was observed following a<br />single topical dose of 0.08%, 0.2% and 0.5%.</p><p>b) Characteristics in patients</p><p>Characteristics in elderly patients:</p><p>The Cmax, AUC, and apparent half-life of brimonidine are similar in the elderly (subjects 65 years or<br />older) after a single dose compared with young adults, indicating that its systemic absorption and<br />elimination are not affected by age.</p><p>Based on data from a 3 month clinical study, which included elderly patients, systemic exposure to<br />brimonidine was very low.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety<br />pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Benzalkonium Chloride<br />Poly(vinyl alcohol)<br />Sodium chloride<br />Sodium citrate<br />Citric acid<br />Purified water<br />Hydrochloric acid (for pH-adjustment) or<br />Sodium hydroxide (for pH-adjustment)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.&nbsp;Discard after 30 days or opening</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10 ml LDPE opaque bottle</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Co., 
Plot No. ME1:3, 
Phase V, 
Industrial City, 
Jeddah,
Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09-2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>